Cause of neural death in neurodegenerative diseases attributable to expansion of glutamine repeats
The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Abstract
Neurodegenerative diseases resulting from expanded repeat sequences of glutamine residues are associated with the formation of protein aggregates in the cell nuclei of the affected neurons, but whether these are pathogenic is controversial. Recent observations indicate that the ages of onset of these diseases are exponential functions of the repeat lengths and that the probability of neural death is constant with time. The only process known to us that could give rise to such behaviour is nucleation of the aggregates.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The number of these repeats determines both the time of onset of observable disease (more repeats meaning earlier onset) (Perutz and Windle 2001; Ross 1995; Walters and Murphy 2009), accounting for 70% of the variance (Imarisio et al. 2008), and the disease severity, implying that it is indeed the polyglutamines themselves that are the chief culprits.”
Citations
Cites
Aggregation of Huntingtin in Neuronal Intranuclear Inclusions and Dystrophic Neurites in Brain
DiFiglia, M., Sapp, E., Chase, K. O., Davies, S. W., Bates, G. P., Vonsattel, J. P., & Aronin, N. (1997) · Science · doi:10.1126/science.277.5334.1990 · Cited by 2,439 · cited 1×
“This adhesive property causes the proteins that possess expanded glutamine repeats to form aggregates in the nuclei of affected neuron”
BackgroundDavies, S. W., Turmaine, M., Cozens, B. A., DiFiglia, M., Sharp, A. H., Ross, C. A., Scherzinger, E., Wanker, E. E., Mangiarini, L., & Bates, G. P. (1997) · Cell · doi:10.1016/s0092-8674(00)80513-9 · Cited by 2,181 · cited 1×
“This adhesive property causes the proteins that possess expanded glutamine repeats to form aggregates in the nuclei of affected neuron”
BackgroundSaudou, F., Finkbeiner, S., Devys, D., & Greenberg, M. E. (1998) · Cell · doi:10.1016/s0092-8674(00)81782-1 · Cited by 1,595 · cited 1×
“Conclusions In cell or animal models, investigators have reported cell death without aggregates and aggregates without cell deat”
BackgroundScherzinger, E., Lurz, R., Turmaine, M., Mangiarini, L., Hollenbach, B., Hasenbank, R., Bates, G. P., Davies, S. W., Lehrach, H., & Wanker, E. E. (1997) · Cell · doi:10.1016/s0092-8674(00)80514-0 · Cited by 1,291 · cited 1×
“The number of repeats that causes aggregation of the Huntington's protein in vitro is the same as the number that causes the diseas”
BackgroundNucifora, F. C., Sasaki, M., Peters, M. F., Huang, H., Cooper, J. K., Yamada, M., Takahashi, H., Tsuji, S., Troncoso, J., Dawson, V. L., et al. (2001) · Science · doi:10.1126/science.1056784 · Cited by 1,094
Reversal of Neuropathology and Motor Dysfunction in a Conditional Model of Huntington's Disease
Yamamoto, A., Lucas, J. J., & Hen, R. (2000) · Cell · doi:10.1016/s0092-8674(00)80623-6 · Cited by 1,067 · cited 1×
“In transgenic mice, the formation of nuclear inclusions precedes the development of symptoms, whereas inhibition of the expression of the Huntington's gene causes regression of both aggregates and symptom”
BackgroundGlutamine repeats as polar zippers: their possible role in inherited neurodegenerative diseases.
Perutz, M. F., Johnson, T., Suzuki, M., & Finch, J. T. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.12.5355 · Cited by 1,062 · cited 1×
“Synthetic poly-L-glutamine aggregates into pleated β-sheets that are linked by hydrogen bonds between both their main-chain and side-chain amide”
BackgroundSelf-citationAtaxin-1 with an expanded glutamine tract alters nuclear matrix-associated structures
Skinner, P. J., Koshy, B. T., Cummings, C. J., Klement, I. A., Helin, K., Servadio, A., Zoghbi, H. Y., & Orr, H. T. (1997) · Nature · doi:10.1038/40153 · Cited by 523 · cited 1×
“Conclusions In cell or animal models, investigators have reported cell death without aggregates and aggregates without cell deat”
BackgroundMolecular genetics: Unmasking polyglutamine triggers in neurodegenerative disease
Gusella, J. F., & MacDonald, M. E. (2000) · Nature Reviews Neuroscience · doi:10.1038/35039051 · Cited by 404
Huntington aggregates may not predict neuronal death in Huntington's disease.
Kuemmerle, S., Gutekunst, C., Klein, A., Li, X. J., Li, S. H., Beal, M. F., Hersch, S. M., & Ferrante, R. J. (1999) · PubMed · Cited by 362
Research works printed but not linked: 1
- Mullins, J. W. Crystallisation 2nd edn (Butterworth, London, 1972).
Cited by
Fabrication of novel biomaterials through molecular self-assembly
Zhang, S. (2003) · Nature Biotechnology · doi:10.1038/nbt874 · Cited by 3,347
Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases
Bucciantini, M., Giannoni, E., Chiti, F., Baroni, F., Formigli, L., Zurdo, J., Taddei, N., Ramponi, G., Dobson, C. M., & Stefani, M. (2002) · Nature · doi:10.1038/416507a · Cited by 2,434
Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death
Arrasate, M., Mitra, S., Schweitzer, E. S., Segal, M. R., & Finkbeiner, S. (2004) · Nature · doi:10.1038/nature02998 · Cited by 1,979
Stefani, M., & Dobson, C. M. (2003) · Journal of Molecular Medicine · doi:10.1007/s00109-003-0464-5 · Cited by 1,651
Caughey, B., & Lansbury, P. T. (2003) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.26.010302.081142 · Cited by 1,650
The roles of intracellular protein-degradation pathways in neurodegeneration
Rubinsztein, D. C. (2006) · Nature · doi:10.1038/nature05291 · Cited by 1,625
Folding proteins in fatal ways
Selkoe, D. J. (2003) · Nature · doi:10.1038/nature02264 · Cited by 1,417
Biomimetic materials for tissue engineering
Ma, P. X. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.08.041 · Cited by 1,310
“Perutz demonstrated the formation of nanotubes from polyglutamines [79-81].”
BackgroundThe Ubiquitin Proteasome System in Neurodegenerative Diseases
Ciechanover, A., & Brundin, P. (2003) · Neuron · doi:10.1016/s0896-6273(03)00606-8 · Cited by 982
Principles of protein folding, misfolding and aggregation
Dobson, C. M. (2004) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2003.12.008 · Cited by 904
“Such seeding events are also likely to be the reason why some deposition conditions such as Alzheimer’s disease progress so rapidly once the initial symptoms are evident [69,89].”
BackgroundA century-old debate on protein aggregation and neurodegeneration enters the clinic
Lansbury, P. T., & Lashuel, H. A. (2006) · Nature · doi:10.1038/nature05290 · Cited by 687
Huntington's disease age-of-onset linked to polyglutamine aggregation nucleation
Chen, S., Ferrone, F. A., & Wetzel, R. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.182276099 · Cited by 523
Mutant huntingtin impairs axonal trafficking in mammalian neurons in vivo and in vitro
Trushina, E., Dyer, R. B., Badger, J. D., Ure, D., Eide, L., Tran, D. D., Vrieze, B. T., Legendre-Guillemin, V., McPherson, P. S., Mandavilli, B. S., et al. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.18.8195-8209.2004 · Cited by 520
“However, most data suggest that polyglutamine-mediated aggregation contributes to the pathology (32).”
BackgroundYao, D., Gu, Z., Nakamura, T., Shi, Z.-Q., Ma, Y., Gaston, B., Palmer, L. A., Rockenstein, E. M., Zhang, Z., Masliah, E., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0404161101 · Cited by 515
Huntington’s Disease: Mechanisms of Pathogenesis and Therapeutic Strategies
Jimenez-Sanchez, M., Licitra, F., Underwood, B. R., & Rubinsztein, D. C. (2017) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a024240 · Cited by 507
Amyloid fibers are water-filled nanotubes
Perutz, M. F., Finch, J. T., Berriman, J., & Lesk, A. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.042681399 · Cited by 506
Self-citationStructures for amyloid fibrils
Makin, O. S., & Serpell, L. C. (2005) · The FEBS Journal · doi:10.1111/j.1742-4658.2005.05025.x · Cited by 461
Finney, E. E., & Finke, R. G. (2008) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2007.05.092 · Cited by 377
Kell, D. B. (2010) · Archives of Toxicology · doi:10.1007/s00204-010-0577-x · Cited by 361
“The number of these repeats determines both the time of onset of observable disease (more repeats meaning earlier onset) (Perutz and Windle 2001; Ross 1995; Walters and Murphy 2009), accounting for 70% of the variance (Imarisio et al. 2008), and the disease severity, implying that it is indeed…”
BackgroundCell cycle regulation of neuronal apoptosis in development and disease
Becker, E. B. E., & Bonni, A. (2004) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2003.12.005 · Cited by 302
Aggregate formation inhibits proteasomal degradation of polyglutamine proteins
Verhoef, L. G. G. C. (2002) · Human Molecular Genetics · doi:10.1093/hmg/11.22.2689 · Cited by 292
“Recent studies providing evidence for a ‘one-hit model’ in neurodegeneration (14) have inspired Perutz and Windle (15) to postulate that the nucleation of misfolded proteins into aggregates is the single biochemical event that initiates neurodegeneration.”
BackgroundOn the wrong DNA track: Molecular mechanisms of repeat-mediated genome instability
Khristich, A. N., & Mirkin, S. M. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.rev119.007678 · Cited by 289
“It was initially thought that this is because repeat-associated toxicity is low and results in a slow, gradual degradation of patients’ tissues that becomes symptomatic later in life (241, 242).”
BackgroundA kinetic study of β‐lactoglobulin amyloid fibril formation promoted by urea
Hamada, D., & Dobson, C. M. (2002) · Protein Science · doi:10.1110/ps.0217702 · Cited by 280
“…amyloid fibrils is a nucleation-dependent process in which initial species produced by the association of specific regions of denatured proteins plays an important role in initiating the process (Jarrett and Lansbury 1993; Lomakin et al. 1996, 1997; Naiki and Nakakuki 1996; Perutz and Windle 2001).”
BackgroundSpinocerebellar ataxias in the Netherlands: Prevalence and age at onset variance analysis
van de Warrenburg, B. P. C., Sinke, R. J., Verschuuren–Bemelmans, C. C., Scheffer, H., Brunt, E. R., Ippel, P. F., Maat–Kievit, J. A., Dooijes, D., Notermans, N. C., Lindhout, D., et al. (2002) · Neurology · doi:10.1212/wnl.58.5.702 · Cited by 254
Antioxidants as treatment for neurodegenerative disorders
Moosmann, B., & Behl, C. (2002) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.11.10.1407 · Cited by 252
Protein Folding and Aggregation into Amyloid: The Interference by Natural Phenolic Compounds
Stefani, M., & Rigacci, S. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms140612411 · Cited by 238
A transgenic mouse model of the ubiquitin/proteasome system
Lindsten, K., Menéndez-Benito, V., Masucci, M. G., & Dantuma, N. P. (2003) · Nature Biotechnology · doi:10.1038/nbt851 · Cited by 234
Pathogenesis of polyglutamine disorders: aggregation revisited
Michalik, A., & Van Broeckhoven, C. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddg295 · Cited by 232
Observation of sequence specificity in the seeding of protein amyloid fibrils
Krebs, M. R. H., Morozova‐Roche, L. A., Daniel, K., Robinson, C. V., & Dobson, C. M. (2004) · Protein Science · doi:10.1110/ps.04707004 · Cited by 228
“This process is similar to the well-established seeding phenomenon in crystallization and has been associated with the transmission of the TSEs and with the rapid development of disorders such as Alzheimer’s disease once clinical symptoms are detected (Jarrett and Lansbury 1993; Perutz and Windle 2001; Korth et al. 20…”
BackgroundPerutz, M. F., Pope, B. J., Owen, D., Wanker, E. E., & Scherzinger, E. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.042681599 · Cited by 216
Self-citationWang, Q., Johnson, J. L., Agar, N. Y. R., & Agar, J. N. (2008) · PLoS Biology · doi:10.1371/journal.pbio.0060170 · Cited by 198
“The authors of this previous study concluded that disease onset correlates with rate of nucleation of aggregation [81].”
BackgroundCarmichael, J., Sugars, K. L., Bao, Y. P., & Rubinsztein, D. C. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m204861200 · Cited by 195
Stefani, M. (2010) · The FEBS Journal · doi:10.1111/j.1742-4658.2010.07889.x · Cited by 183
Halfmann, R., Alberti, S., Krishnan, R., Lyle, N., O'Donnell, C. W., King, O. D., Berger, B., Pappu, R. V., & Lindquist, S. (2011) · Molecular Cell · doi:10.1016/j.molcel.2011.05.013 · Cited by 179
“Both the severity of the disease and the aggregation tendency of the protein are correlated with the length of the polyQ tract (Perutz and Windle, 2001).”
Kinetic control of dimer structure formation in amyloid fibrillogenesis
Hwang, W., Zhang, S., Kamm, R. D., & Karplus, M. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0402634101 · Cited by 177
Garden, G. A., Libby, R. T., Fu, Y.-H., Kinoshita, Y., Huang, J., Possin, D. E., Smith, A. C., Martinez, R. A., Fine, G. C., Grote, S. K., et al. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-12-04897.2002 · Cited by 167
“Other investigators nonetheless argue that the process of aggregate formation is pathogenic, because development of NIs typically precedes onset of neuronal dysfunction (Perutz and Windle, 2001).”
BackgroundThe Amyloid β Peptide (Aβ1-40) Is Thermodynamically Soluble at Physiological Concentrations
Sengupta, P., Garai, K., Sahoo, B., Shi, Y., Callaway, D. J. E., & Maiti, S. (2003) · Biochemistry · doi:10.1021/bi0341410 · Cited by 167
Recent Advancements of Nanomedicine in Neurodegenerative Disorders Theranostics
Mukherjee, S., Madamsetty, V. S., Bhattacharya, D., Roy Chowdhury, S., Paul, M. K., & Mukherjee, A. (2020) · Advanced Functional Materials · doi:10.1002/adfm.202003054 · Cited by 152
Bevivino, A. E., & Loll, P. J. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.211305198 · Cited by 193
Inclusion bodies: Specificity in their aggregation process and amyloid-like structure
Morell, M., Bravo, R., Espargaró, A., Sisquella, X., Avilés, F. X., Fernàndez‐Busquets, X., & Ventura, S. (2008) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2008.06.007 · Cited by 153
“This effect has been associated with the transmission of the TSEs and with the rapid development of Alzheimer's disease once clinical symptoms are detected [52,53].”
BackgroundNagai, Y. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddg144 · Cited by 144
Cornman, R. S., Togawa, T., Dunn, W. A., He, N., Emmons, A. C., & Willis, J. H. (2008) · BMC Genomics · doi:10.1186/1471-2164-9-22 · Cited by 158
Chavez Zobel, A. T. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddg173 · Cited by 141
Uptain, S. M., Sawicki, G. J., Caughey, B. W., & Lindquist, S. L. (2001) · The EMBO Journal · doi:10.1093/emboj/20.22.6236 · Cited by 149
Structure and function of amyloid in Alzheimer's disease
Morgan, C., Colombres, M., Núñez, M. T., & Inestrosa, N. C. (2004) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2004.10.004 · Cited by 176
A cell-based screen for drugs to treat Huntington's disease
Aiken, C. T., Tobin, A. J., & Schweitzer, E. S. (2004) · Neurobiology of Disease · doi:10.1016/j.nbd.2004.04.001 · Cited by 135
“…these aggregates are causal, protective, or incidental remains hotly debated (Bence et al., 2001; Davies et al., 1997; Hackam et al., 1998; Hughes and Olson, 2001; Kim et al., 1999; Perutz and Windle, 2001; Saudou et al., 1998; Waelter et al., 2001; Wang et al., 1999; Wellington et al., 2000).”
BackgroundHarrison, P. M., & Gerstein, M. (2003) · Genome biology · doi:10.1186/gb-2003-4-6-r40 · Cited by 147
“This disorder is caused by inherited expansions of length equal or greater than 39 amino-acid residues in the polyglutamine region of the protein huntingtin [15].”
BackgroundThe Domain-Swapped Dimer of Cyanovirin-N Is in a Metastable Folded State
Barrientos, L. G., Louis, J. M., Botos, I., Mori, T., Han, Z., O’Keefe, B. R., Boyd, M. R., Wlodawer, A., & Gronenborn, A. M. (2002) · Structure · doi:10.1016/s0969-2126(02)00758-x · Cited by 125
Measey, T. J., & Schweitzer‐Stenner, R. (2010) · Journal of the American Chemical Society · doi:10.1021/ja1089827 · Cited by 125
Andreassen, O. (2002) · Neurobiology of Disease · doi:10.1006/nbdi.2002.0562 · Cited by 123
King, M. A., Hands, S., Hafiz, F., Mizushima, N., Tolkovsky, A. M., & Wyttenbach, A. (2008) · Molecular Pharmacology · doi:10.1124/mol.107.043398 · Cited by 120
“It is thought that polyQ aggregation follows a stochastic nucleation dependent process that initiates oligomerisation, amyloid-like fibril formation and the production of structures called inclusion bodies (IBs) (Perutz and Windle, 2001).”
BackgroundRaoul, C., Buhler, E., Sadeghi, C., Jacquier, A., Aebischer, P., Pettmann, B., Henderson, C. E., & Haase, G. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0508774103 · Cited by 115
Fighting disease by selective autophagy of aggregate‐prone proteins
Knævelsrud, H., & Simonsen, A. (2010) · FEBS Letters · doi:10.1016/j.febslet.2010.04.041 · Cited by 113
Degradation of Signal Timing in Cortical Areas V1 and V2 of Senescent Monkeys
Wang, Y. (2005) · Cerebral Cortex · doi:10.1093/cercor/bhh143 · Cited by 112
“result in a degradation of excitatory transmission in a variety of brain diseases (Olney et al., 1998; Perutz and Windle, 2001; Butterfield and Pocernich, 2003; Francis, 2003).”
BackgroundInfluentialAutophagy and polyglutamine diseases
Jimenez-Sanchez, M., Thomson, F., Zavodszky, E., & Rubinsztein, D. C. (2012) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2011.08.013 · Cited by 103
“In general, it is accepted that, although the nature of the toxic forms is not known, the propensity to aggregate is related to neuronal toxicity, which is supported by two facts: First, the length of the polyglutamine tract directly correlates with the tendency to aggregate, and second, the number of polyglutamines d…”
Oxidative stress in Alzheimer’s Disease: Implications for Prevention and Therapy
Behl, C. (2006) · Springer eBooks · doi:10.1007/0-387-23226-5_3 · Cited by 114
Engineering amyloidogenicity towards the development of nanofibrillar materials
Hamada, D., Yanagihara, I., & Tsumoto, K. (2004) · Trends in biotechnology · doi:10.1016/j.tibtech.2003.12.003 · Cited by 100
Singh, G. P., Chandra, B. R., Bhattacharya, A., Akhouri, R. R., Singh, S. K., & Sharma, A. K. (2004) · Molecular and Biochemical Parasitology · doi:10.1016/j.molbiopara.2004.05.016 · Cited by 96
Liu, K.-Y., Shyu, Y., Barbaro, B. A., Lin, Y.-T., Chern, Y., Thompson, L. M., Shen, C.-K. J., & Marsh, J. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu574 · Cited by 110
“Two possiblemechanisms of nuclear disruption include (1) simplemechanical stress or (2) a localized urea-like denaturing propensity recently proposed for polyglutamine structures (9).”
BackgroundDe novo generation of prion strains
Colby, D. W., & Prusiner, S. B. (2011) · Nature Reviews Microbiology · doi:10.1038/nrmicro2650 · Cited by 88
Rapid amyloid fiber formation from the fast-folding WW domain FBP28
Ferguson, N., Berriman, J. A., Petrovich, M., Sharpe, T., Finch, J. T., & Fersht, A. R. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1333907100 · Cited by 96
A Universal Mechanism Ties Genotype to Phenotype in Trinucleotide Diseases
Kaplan, S., Itzkovitz, S., & Shapiro, E. (2007) · PLoS Computational Biology · doi:10.1371/journal.pcbi.0030235 · Cited by 81
Stefani, M. (2007) · The Neuroscientist · doi:10.1177/1073858407303428 · Cited by 89
Huntington’s Disease Pathogenesis Is Modified In Vivo by Alfy/Wdfy3 and Selective Macroautophagy
Fox, L. M., Kim, K., Johnson, C. W., Chen, S., Croce, K. R., Victor, M. B., Eenjes, E., Bosco, J. R., Randolph, L. K., Dragatsis, I., et al. (2020) · Neuron · doi:10.1016/j.neuron.2019.12.003 · Cited by 76
“correlation between mutation length and an earlier age of disease onset (MacDonald and Gusella, 1996; Perutz and Windle, 2001).”
BackgroundRole of Heat Shock Proteins During Polyglutamine Neurodegeneration: Mechanisms and Hypothesis
Wyttenbach, A. (2004) · Journal of Molecular Neuroscience · doi:10.1385/jmn:23:1-2:069 · Cited by 79
“Perutz and Windle (2001) have argued that the only process giving rise to such behavior is predicted to be the nucleation of the aggregates.”
BackgroundMarchal, S., Shehi, E., Harricane, M., Fusi, P., Heitz, F., Tortora, P., & Lange, R. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m304205200 · Cited by 64
Proteasome degrades soluble expanded polyglutamine completely and efficiently
Michalik, A., & Broeckhoven, C. V. (2004) · Neurobiology of Disease · doi:10.1016/j.nbd.2003.12.020 · Cited by 68
Paul, I., Cui, J., & Maynard, E. L. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0604150103 · Cited by 71
Stochastic kinetics of intracellular huntingtin aggregate formation
Colby, D. W., Cassady, J. P., Lin, G. C., Ingram, V. M., & Wittrup, K. D. (2006) · Nature Chemical Biology · doi:10.1038/nchembio792 · Cited by 69
Garai, K., Sahoo, B., Sengupta, P., & Maiti, S. (2008) · The Journal of Chemical Physics · doi:10.1063/1.2822322 · Cited by 66
Polyglutamine Aggregation in Huntington Disease: Does Structure Determine Toxicity?
Hoffner, G., & Djian, P. (2014) · Molecular Neurobiology · doi:10.1007/s12035-014-8932-1 · Cited by 71
“nature of nucleation [52].”
pH-Dependent Self-Assembly of Polyalanine Peptides
Giri, K., Bhattacharyya, N. P., & Basak, S. (2006) · Biophysical Journal · doi:10.1529/biophysj.106.091769 · Cited by 67
Berciano, M. T., Villagra, N. T., Ojeda, J. L., Navascues, J., Gomes, A., Lafarga, M., & Carmo-Fonseca, M. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh101 · Cited by 65
Insoluble TATA-binding protein accumulation in Huntington’s disease cortex
van Roon‐Mom, W., Reid, S. J., Jones, A. L., MacDonald, M. E., Faull, R. L. M., & Snell, R. G. (2002) · Molecular Brain Research · doi:10.1016/s0169-328x(02)00450-3 · Cited by 70
Dorsman, J. C. (2002) · Human Molecular Genetics · doi:10.1093/hmg/11.13.1487 · Cited by 58
Amyloid Nucleation and Hierarchical Assembly of Ure2p Fibrils
Jiang, Y., Li, H., Zhu, L. Q., Zhou, J.-M., & Perrett, S. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m310494200 · Cited by 60
Beste, C., Carsten Saft, C., Yordanova, J., Andrich, J., Gold, R., Falkenstein, M., & Kolev, V. (2007) · Neuropsychologia · doi:10.1016/j.neuropsychologia.2007.06.004 · Cited by 54
Association of ataxin-7 with the proteasome subunit S4 of the 19S regulatory complex
Matilla, A. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.24.2821 · Cited by 53
Complexity and Heterogeneity: What Drives the Ever‐changing Brain in Huntington's Disease?
Rosas, H. D., Salat, D. H., Lee, S. Y., Zaleta, A. K., Hevelone, N. D., & Hersch, S. M. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1427.034 · Cited by 59
Zhang, H., Rajasekaran, N. S., Orosz, A., Xiao, X., Rechsteiner, M., & Benjamin, I. J. (2010) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2010.09.004 · Cited by 54
“Although the precise pathogenic roles of protein aggregates remain controversial in disease progression [15,16], such pathogenomic hallmarks are associated with increased morbidity and decreased lifespan in both experimental models and in humans [17].”
BackgroundAutophagy-mediated clearance of ubiquitinated mutant huntingtin by graphene oxide
Jin, P., Wei, P., Zhang, Y., Lin, J., Sha, R., Hu, Y. B., Zhang, J., Zhou, W., Yao, H. H., Ren, L., et al. (2016) · Nanoscale · doi:10.1039/c6nr07255k · Cited by 51
Hoffner, G., & Djian, P. (2014) · Brain Sciences · doi:10.3390/brainsci4010091 · Cited by 54
“could occur rarely within a neuron, but once nucleated, the aggregate would grow rapidly [63].”
BackgroundAndré, W., Sandt, C., Dumas, P., Djian, P., & Hoffner, G. (2013) · Analytical Chemistry · doi:10.1021/ac400038b · Cited by 50
On the Stability of the Soluble Amyloid Aggregates
Sahoo, B., Nag, S., Sengupta, P., & Maiti, S. (2009) · Biophysical Journal · doi:10.1016/j.bpj.2009.05.055 · Cited by 52
“Simple nucleation theories suggest that postnucleation particles should continue to grow indefinitely in a saturated solution (14,15).”
BackgroundSelection and Slippage Creating Serine Homopolymers
Huntley, M. A., & Golding, G. B. (2006) · Molecular Biology and Evolution · doi:10.1093/molbev/msl073 · Cited by 51
“This has been used to explain how extended glutamine repeats in some human neurological proteins induce their associated neurodegenerative diseases (Perutz and Windle 2001).”
BackgroundScheuing, L., Chiu, C., Liao, H., Linares, G. R., & Chuang, D. (2014) · International Journal of Biological Sciences · doi:10.7150/ijbs.9898 · Cited by 47
“Some investigators have suggested that cytoplasmic insoluble mHtt aggregates are a beneficial coping response [53], while others have suggested that intracellular aggregates may be directly toxic [54], and thus the function of mHtt aggregates within the cytoplasm is not definitively known.”
BackgroundPQBP-1 transgenic mice show a late-onset motor neuron disease-like phenotype
Okuda, T., Hattori, H., Takeuchi, S., Shimizu, J., Ueda, H., Palvimo, J. J., Kanazawa, I., Kawano, H., Nakagawa, M., & Okazawa, H. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddg084 · Cited by 40
Brandis, K. A., Holmes, I. F., England, S. J., Sharma, N., Kukreja, L., & DebBurman, S. K. (2006) · Journal of Molecular Neuroscience · doi:10.1385/jmn:28:2:179 · Cited by 45
“…et al., 1999; Li et al., 2001; Shtilerman et al., 2002) and other toxic proteins in neurodegenerative diseases Journal of Molecular Neuroscience Volume 28, 2006 (Eigen, 1996; Perutz and Windle, 2001; Caughey and Lansbury, 2003), yet live cell and in vivo support have only recently been forthcoming.”
BackgroundGong, B., Lim, M., Wanderer, J. P., Wyttenbach, A., & Morton, A. J. (2007) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2007.08.005 · Cited by 46
Phase Transition of Huntingtin: Factors and Pathological Relevance
Yang, J., & Yang, X. (2020) · Frontiers in Genetics · doi:10.3389/fgene.2020.00754 · Cited by 34
“Peskett et al. (2018) also looked at polyQ length and the P-rich region for their roles in mHtt phase transition.”
BackgroundInfluentialMitochondrial dynamics and its impact on human health and diseases: inside the DRP1 blackbox
Banerjee, R., Mukherjee, A., & Nagotu, S. (2021) · Journal of Molecular Medicine · doi:10.1007/s00109-021-02150-7 · Cited by 40
“HD is primarily caused by a mutation in the Huntingtin gene (HTT) that results in the expansion of polyglutamine (CAG) repeats in the HTT protein [123, 124].”
BackgroundStructural modeling of ataxin‐3 reveals distant homology to adaptins
Albrecht, M., Hoffmann, D. E., Evert, B. O., Schmitt, I., Wüllner, U., & Lengauer, T. (2002) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.10280 · Cited by 53
Tagawa, K., Hoshino, M., Okuda, T., Ueda, H., Hayashi, H., Engemann, S., Okado, H., Ichikawa, M., Wanker, E. E., & Okazawa, H. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02372.x · Cited by 37
A Route for Prion Neuroinvasion
Nicotera, P. (2001) · Neuron · doi:10.1016/s0896-6273(01)00385-3 · Cited by 36
“Vagal spreading lead- the probability of neuronal death depends on aggregate accumulation (Perutz and Windle, 2001), in transmissibleing to accumulation of prions in the dorsal motor nucleus could be an alternative route (Beekes et al., 1998).”
BackgroundApolipoprotein E genotypes do not influence the age of onset in Huntington's disease
Saft, C., Andrich, J. E., Brune, N., Gencik, M., Kraus, P. H., Przuntek, H., & Epplen, J. T. (2004) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2003.022756 · Cited by 35
Neurodegenerative diseases and neuroinflammation-induced apoptosis
Huang, S., Lu, Y., Fang, W., Huang, Y., Li, Q., & Xu, Z. (2025) · Open Life Sciences · doi:10.1515/biol-2022-1051 · Cited by 39
Polymer Directed Protein Assemblies
van Rijn, P. (2013) · Polymers · doi:10.3390/polym5020576 · Cited by 32
“While the proteins by themselves do not necessarily aggregate, it is often associated with partial denaturation or from partial cleavage creating a polypeptide, which induces the aggregation, or because of a polypeptide mutation (polyglutamine) [2,3].”
BackgroundTransglutaminase and diseases of the central nervous system.
Hoffner, G., & Djian, P. (2005) · Frontiers in Bioscience · doi:10.2741/1764 · Cited by 33
Polyglutamine repeats and β‐helix structure: Molecular dynamics study
Merlino, A., Esposito, L., & Vitagliano, L. (2006) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.20941 · Cited by 31
The Emerging Landscape of Natural Small-molecule Therapeutics for Huntington’s Disease
Bhat, S. A., Ahamad, S., Dar, N. J., Siddique, Y. H., & Nazir, A. (2023) · Current Neuropharmacology · doi:10.2174/1570159x21666230216104621 · Cited by 31
“Further, it was demonstrated that the extent of poly-glutamine residues corresponds with aggregation and the disease onset, implying an unswerving relationship between aggregation and cell toxicity [33, 34, 37, 38].”
Background
Metadata
- Authors
- Perutz, M. F., & Windle, A. H.
- Affiliations
- MRC Laboratory of Molecular Biology (GB)
- University of Cambridge (GB)
- Venue
- Nature
- Published
- 2001-07
- Volume
- 412
- Issue
- 6843
- Pages
- 143-144
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1548441884
- Cited by
- 199
- References
- 18
- Citations by year
- 2026: 3 · 2025: 1 · 2024: 3 · 2023: 3 · 2021: 3 · 2020: 3 · 2019: 3 · 2018: 3 · 2017: 2 · 2016: 6 · 2015: 4 · 2014: 5 · 2013: 4 · 2012: 8
- FWCI
- 8.99
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Genetic Neurodegenerative Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Prion Diseases and Protein Misfolding
- Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
- Keywords
- neurodegenerative diseases, protein aggregation, intranuclear inclusions, age of onset, nucleation, repeat length, pathogenesis
- MeSH terms
- Animals, Cell Nucleus, Glutamine, Humans, Huntington Disease, Neurons, Cell Death, Age of Onset, Neurodegenerative Diseases, Repetitive Sequences, Amino Acid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.